Literature DB >> 26419858

Identification of dual-tropic HIV-1 using evolved neural networks.

Gary B Fogel1, Susanna L Lamers2, Enoch S Liu1, Marco Salemi3, Michael S McGrath4.   

Abstract

Blocking the binding of the envelope HIV-1 protein to immune cells is a popular concept for development of anti-HIV therapeutics. R5 HIV-1 binds CCR5, X4 HIV-1 binds CXCR4, and dual-tropic HIV-1 can bind either coreceptor for cellular entry. R5 viruses are associated with early infection and over time can evolve to X4 viruses that are associated with immune failure. Dual-tropic HIV-1 is less studied; however, it represents functional antigenic intermediates during the transition of R5 to X4 viruses. Viral tropism is linked partly to the HIV-1 envelope V3 domain, where the amino acid sequence helps dictate the receptor a particular virus will target; however, using V3 sequence information to identify dual-tropic HIV-1 isolates has remained difficult. Our goal in this study was to elucidate features of dual-tropic HIV-1 isolates that assist in the biological understanding of dual-tropism and develop an approach for their detection. Over 1559 HIV-1 subtype B sequences with known tropisms were analyzed. Each sequence was represented by 73 structural, biochemical and regional features. These features were provided to an evolved neural network classifier and evaluated using balanced and unbalanced data sets. The study resolved R5X4 viruses from R5 with an accuracy of 81.8% and from X4 with an accuracy of 78.8%. The approach also identified a set of V3 features (hydrophobicity, structural and polarity) that are associated with tropism transitions. The ability to distinguish R5X4 isolates will improve computational tropism decisions for R5 vs. X4 and assist in HIV-1 research and drug development efforts.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Artificial neural network; Evolutionary computation; HIV phenotype; HIV-1 coreceptor; Viral tropism

Mesh:

Year:  2015        PMID: 26419858      PMCID: PMC4921197          DOI: 10.1016/j.biosystems.2015.09.007

Source DB:  PubMed          Journal:  Biosystems        ISSN: 0303-2647            Impact factor:   1.973


  80 in total

1.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

Review 2.  Coreceptors and HIV-1 pathogenesis.

Authors:  Paul R Gorry; Petronela Ancuta
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

3.  Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.

Authors:  Elena Delgado; Aurora Fernández-García; Yolanda Vega; Teresa Cuevas; Milagros Pinilla; Valentina García; Mónica Sánchez; María González; Ana María Sánchez; Michael M Thomson; Lucía Pérez-Álvarez
Journal:  J Antimicrob Chemother       Date:  2011-10-18       Impact factor: 5.790

4.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

5.  High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.

Authors:  Mattias Mild; Rebecca R Gray; Anders Kvist; Philippe Lemey; Maureen M Goodenow; Eva Maria Fenyö; Jan Albert; Marco Salemi; Joakim Esbjörnsson; Patrik Medstrand
Journal:  Infect Genet Evol       Date:  2013-05-11       Impact factor: 3.342

6.  The characterization of amino acid sequences in proteins by statistical methods.

Authors:  J M Zimmerman; N Eliezer; R Simha
Journal:  J Theor Biol       Date:  1968-11       Impact factor: 2.691

7.  Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.

Authors:  S V Gulnik; L I Suvorov; B Liu; B Yu; B Anderson; H Mitsuya; J W Erickson
Journal:  Biochemistry       Date:  1995-07-25       Impact factor: 3.162

8.  Hydrophobicity of amino acid residues in globular proteins.

Authors:  G D Rose; A R Geselowitz; G J Lesser; R H Lee; M H Zehfus
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

9.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

10.  R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Authors:  Silvana Tasca; Siu-Hong Ho; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

View more
  2 in total

1.  Predicted coreceptor usage at end-stage HIV disease in tissues derived from subjects on antiretroviral therapy with an undetectable plasma viral load.

Authors:  S L Lamers; G B Fogel; E S Liu; D J Nolan; M Salemi; A E Barbier; R Rose; E J Singer; M S McGrath
Journal:  Infect Genet Evol       Date:  2017-04-06       Impact factor: 3.342

2.  Brain-specific HIV Nef identified in multiple patients with neurological disease.

Authors:  Susanna L Lamers; Gary B Fogel; Enoch S Liu; Andrew E Barbier; Christopher W Rodriguez; Elyse J Singer; David J Nolan; Rebecca Rose; Michael S McGrath
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.